Magdalena Thurin PhD

Magdalena Thurin’s, Ph.D. major focus has been on validation of biomarkers for clinical application in cancer with specific interest on the cutting-edge areas of molecular markers in melanoma and the immune response markers for prognosis and prediction of response to treatment. Prior to joining NCI in 2001 she conducted research at The Wistar Institute of Anatomy and Biology in Philadelphia focusing on structural and functional characterization of carbohydrate antigens and application for diagnosis including Sialyl-Lewis A (SA-Le A) that became a diagnostic test for pancreatic and colon cancer (CA 19-9).